NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 25 04:00PM ET
0.3500
Dollar change
-0.0100
Percentage change
-2.78
%
Index- P/E- EPS (ttm)-1.22 Insider Own7.73% Shs Outstand33.05M Perf Week0.75%
Market Cap11.75M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float30.98M Perf Month-15.99%
Income-37.64M PEG- EPS next Q-0.33 Inst Own17.05% Short Float0.47% Perf Quarter-56.47%
Sales0.77M P/S15.26 EPS this Y26.61% Inst Trans29.27% Short Ratio0.76 Perf Half Y-72.44%
Book/sh1.64 P/B0.21 EPS next Y- ROA-43.06% Short Interest0.14M Perf Year-69.57%
Cash/sh0.89 P/C0.39 EPS next 5Y- ROE-53.65% 52W Range0.28 - 2.23 Perf YTD-53.33%
Dividend Est.- P/FCF- EPS past 5Y-27.40% ROI-67.76% 52W High-84.30% Beta0.81
Dividend TTM- Quick Ratio4.27 Sales past 5Y6885.34% Gross Margin-208.60% 52W Low24.96% ATR (14)0.05
Dividend Ex-Date- Current Ratio4.41 EPS Y/Y TTM-3.48% Oper. Margin-5613.47% RSI (14)42.46 Volatility9.85% 17.79%
Employees132 Debt/Eq0.04 Sales Y/Y TTM-88.70% Profit Margin-4887.88% Recom3.00 Target Price1.00
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q28.92% Payout- Rel Volume0.11 Prev Close0.36
Sales Surprise-60.19% EPS Surprise-5.88% Sales Q/Q-95.80% EarningsMar 27 AMC Avg Volume190.70K Price0.35
SMA202.95% SMA50-23.26% SMA200-62.39% Trades Volume21,838 Change-2.78%
Date Action Analyst Rating Change Price Target Change
Aug-12-22Downgrade Sidoti Buy → Neutral $5
Dec-29-21Initiated Sidoti Buy $14
Mar-29-21Downgrade Maxim Group Buy → Hold
May-20-20Upgrade Maxim Group Hold → Buy
May-18-20Reiterated H.C. Wainwright Buy $20 → $35
Mar-09-20Reiterated H.C. Wainwright Buy $4 → $20
Mar-03-20Downgrade Maxim Group Buy → Hold
Apr-02-25 12:00PM
Mar-28-25 08:45AM
03:03AM
Mar-27-25 07:05PM
06:44PM
04:01PM Loading…
04:01PM
Mar-19-25 05:20PM
Mar-13-25 09:30AM
Mar-06-25 03:30PM
Mar-03-25 09:30AM
Feb-24-25 08:18AM
Feb-21-25 04:00PM
Jan-30-25 09:30AM
Jan-07-25 09:30AM
Dec-10-24 09:30AM
10:03AM Loading…
Nov-08-24 10:03AM
Nov-07-24 04:01PM
Nov-05-24 09:30AM
Oct-25-24 04:01PM
Oct-21-24 09:30AM
Oct-09-24 05:58PM
Oct-02-24 09:30AM
Sep-24-24 09:30AM
Sep-05-24 09:30AM
Aug-15-24 09:30AM
Aug-08-24 04:01PM
Jul-29-24 09:30AM
Jul-25-24 09:30AM
Jul-02-24 09:30AM
Jun-18-24 01:30PM
09:30AM Loading…
Jun-14-24 09:30AM
May-10-24 01:16PM
May-09-24 08:58PM
04:01PM
Apr-25-24 09:30AM
Apr-24-24 09:30AM
Apr-12-24 09:30AM
Apr-04-24 09:30AM
Mar-21-24 09:30AM
Mar-18-24 09:30AM
Mar-15-24 03:21PM
05:45AM
Mar-14-24 08:55PM
04:01PM
Mar-07-24 09:30AM
Feb-29-24 09:30AM
Feb-01-24 09:30AM
Jan-03-24 09:30AM
Dec-27-23 09:30AM
Nov-29-23 09:30AM
Nov-10-23 03:11PM
01:34PM
Nov-09-23 04:01PM
Nov-02-23 09:30AM
Oct-31-23 09:30AM
Oct-26-23 09:30AM
Oct-23-23 09:30AM
Oct-16-23 09:30AM
Sep-27-23 09:30AM
Sep-22-23 09:30AM
Sep-21-23 09:30AM
Sep-07-23 09:30AM
Aug-29-23 09:30AM
Aug-18-23 09:30AM
Aug-16-23 11:30AM
Aug-13-23 07:51AM
Aug-11-23 05:21AM
Aug-10-23 05:15PM
04:01PM
Jul-27-23 09:30AM
Jul-20-23 09:30AM
Jul-18-23 09:30AM
Jul-13-23 09:30AM
May-18-23 07:21AM
May-11-23 05:25PM
04:01PM
May-09-23 09:30AM
May-05-23 10:35AM
Apr-26-23 09:30AM
Apr-13-23 09:30AM
Mar-23-23 09:26AM
Mar-21-23 09:39AM
Mar-20-23 10:46PM
Mar-17-23 09:30AM
06:38AM
Mar-16-23 05:45PM
04:01PM
Mar-09-23 09:30AM
Mar-02-23 09:30AM
Feb-28-23 12:11PM
Feb-22-23 09:30AM
Feb-02-23 09:30AM
Jan-24-23 09:30AM
Jan-05-23 09:30AM
Dec-03-22 07:25AM
Nov-30-22 10:00AM
Nov-16-22 05:17AM
Nov-14-22 09:30AM
Nov-12-22 07:34AM
Nov-10-22 04:13PM
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.